Cancer Genetics, Inc. (CGIX) Heading to the Bottom of the Ocean?

Look at CGIX stock. What do we think about Wednesday’s stock prices? Are we looking at a stock market crash? Possibly we will see stock price increases? On 16 January, Company stock for Cancer Genetics, Inc. (NASDAQ:CGIX) saw trading gains. Stock increased 0.02 points, a 6.56 (%) change, now priced $0.26 with a light trading day between 2.95 million shares. Trading started priced $0.26, and stock prices went to $0.2784 and low prices of $0.24; market cap is at $8.08 million USD with 31.09 million outstanding stocks. Cancer Genetics, Inc. (CGIX) share price decreased -53.15 (%) in last 3 consecutive weeks.

CGIX share price trailing 3-Y Beta is 1.38, making a possible higher RoR yet also presenting more risk. Profit to share is at -$0.29 over last 12 months. Shares increased 7.44 (%) (YTD) for a decline of -87.32 (%) over the last twelve months. Stock prices are -88.18 (%) from year high of $2.20 and 30 with the 52 Week lowest stock price at $0.20. Overall the stocks consensus estimates are 2.5 – out of 5, stock experts rate these shares a sell.

Stocks for Cancer Genetics, Inc. decreased due to 12 earnings reactions and increasing 0.11 (%) on earnings reports.

The Company’s stock prices are at $0.24. With support at $0.22. Up to now CGIX shares trade higher than this price, investors are OK for now. RSI went to 43.44 which is not good. If prices go to below $0.22 more sell-offs are forecasted. However if shares go to $0.28 then we could see trading at a $0.3 price.

It has a 0.29 P/S ratio. Price-to-Sales ratio at 5.82. 29.6 (%) GPM for Cancer Genetics, Inc. with OPM currently at -98.6 (%). NPM is -87 (%).